Immuno-Oncology Forum III: Focus on NSCLC

Immuno-Oncology Forum III: Focus on NSCLC

The rapid evolution and integration of immune checkpoint inhibitors into t…

Expiration Date: 2/28/2019

Max Credits: 0

View Activity

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

For many years, the mainstay of initial treatment for metastatic bladder c…

Expiration Date: 2/23/2019

Max Credits: 0

View Activity

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

The integration of immunotherapies into management strategies for the trea…

Expiration Date: 1/11/2020

Max Credits: 0

View Activity

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

The development and integration of targeted therapies, as well as immunoth…

Expiration Date: 4/10/2018

Max Credits: 0

View Activity

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

Advances in immunology and the advent of immune checkpoint blockade inhibi…

Expiration Date: 4/2/2018

Max Credits: 0

View Activity

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

The integration of immune checkpoint inhibitors into treatment strategies …

Expiration Date: 2/23/2018

Max Credits: 0

View Activity

Combination Strategies in Melanoma Management: What's New and What's Next

Combination Strategies in Melanoma Management: What's New and What's Next

Melanoma is the sixth most common cancer in the United States and the dead…

Expiration Date: 1/23/2018

Max Credits: 0

View Activity

Breakthroughs in the Treatment of Bladder Cancer

Breakthroughs in the Treatment of Bladder Cancer

Assessment of immune checkpoint blockade inhibitors in the treatment of bl…

Expiration Date: 12/13/2017

Max Credits: 0

View Activity

Immuno-oncology Forum: Focus on Non-small Cell Lung Cancer

Immuno-oncology Forum: Focus on Non-small Cell Lung Cancer

Lung cancer accounts for 27% of all cancer deaths in the United States, ma…

Expiration Date: 10/26/2017

Max Credits: 0

View Activity

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

Management of Multiple Myeloma: Using Emerging Therapies with ASCT

Multiple myeloma management has undergone profound changes in the past few…

Expiration Date: 6/1/2017

Max Credits: 0

View Activity